Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer

Summary

This study will evaluate the safety and tolerability of a personalized live, attenuated, double-deleted Listeria monocytogenes (pLADD) treatment in adults with metastatic colorectal cancer.

Timeline

Start

2017-05-02

Primary completion

2019-10-15

Completion

2020-09-02

Outcome

Outcome not reported

Stopped (Business): “Study terminated due to business realignment”

Drugs

Indications